2344. FDA Analysis of CD4+ Cell Count Declines Observed in HIV-Infected Children Treated With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide

Autor: Prabha Viswanathan, Wendy Carter, LaRee Tracy, Yodit Belew, Mario R Sampson, Sung Rhee, Tanvir Bell, Islam R. Younis, Melisse Baylor
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Open Forum Infectious Diseases
ISSN: 2328-8957
Popis: Background Elvitegravir (EVG)/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) is approved for treatment of HIV-1 in children weighing ≥25 kg based on a Gilead sponsored study of safety, pharmacokinetics (PK), and antiviral activity among 23 virologically suppressed (VS) children 6–
Databáze: OpenAIRE